MM+M

MM+M: the most objective, relevant, and timely source of news, analysis, and trends in pharmaceutical and healthcare marketing

[MM+M @MMMnews]

🚨 Pharma marketing is entering a new reality: fragmentation is now the biggest barrier to performance. Join this webinar to find out more

https://t.co/uvRkisr3LW

[MM+M @MMMnews]

🎤 Hear from experts at Yale Cancer Center, Merck & Fullspan Health as they discuss the future of breast cancer support beyond the diagnosis.

📅 June 25 | ⏰ 1 PM ET
🎟️ Free webinar

👉 https://t.co/CnzAKi5myp

#Oncology #BreastCancerCare #DigitalHealth

[MM+M @MMMnews]

The 2025 Salary Survey reveals a major shift: Average pay has dipped to $161K, benefits are tightening and in-office mandates have doubled. Success now requires a blend of data, tech and strategy.

Read the full analysis: https://t.co/j1suG8bl6W

[MM+M @MMMnews]

This year’s Agency 100 tracks a total industry shake-up. 👾

With massive acquisitions rewriting the rules, we’re revealing the high scores of health marketing on June 9.

Register today to see who will level up:
https://t.co/Ct4HRxwhk3

[MM+M @MMMnews]

Five things for pharma marketers to know for Friday, June 5, 2026 https://t.co/FFlVbiKGs5 #MedicalMarketing #Pharma

[MM+M @MMMnews]

Women of Distinction and the medical marketing leaders that pay it forward https://t.co/LS9DoHYwV8

[MM+M @MMMnews]

Fullspan brings AI ‘health companion’ to Healthline as publishers push beyond search https://t.co/tEKo9iHZNP

[MM+M @MMMnews]

Yesterday's event was one for the books! Thank you to everyone who attended #MMMWomenOfDistinction from the panelists, honorees, sponsors and the guests! Congratulations again to all of the honorees and we look forward to seeing your continued success.

[MM+M @MMMnews]

GCI Health's Joe Malunda on why AI may not be the cure for healthcare’s ills, but can democratize health education https://t.co/H3KKzJuFdK @GCIHealth #Opinion

[MM+M @MMMnews]

QOL Medical’s untitled letter from the FDA is a reminder that fine print isn’t enough https://t.co/0PgRlT9ccx

[MM+M @MMMnews]

Ready to play?

The MM+M Agency 100 has leveled up for 2026!

Find your perfect agency partner instantly with our new AI matchmaking tool, MM+M iNTELLIGENCE, plus video showcases and podcasts.

See the new site live June 9: https://t.co/0e0N3wLn1e.

[MM+M @MMMnews]

Five things for pharma marketers to know for Thursday, June 4, 2026 https://t.co/EbE2LO4soI #MedicalMarketing #Pharma

[MM+M @MMMnews]

📉 Privacy pressure is rising — but the real issue in pharma marketing is visibility breakdown.

Join experts from AstraZeneca, Kelley Drye, and Freshpaint to explore what comes next.

🎟️ https://t.co/uvRkisr3LW

[MM+M @MMMnews]

ASCO 2026: Takeaways for healthcare marketers https://t.co/bHDUWU74Il

[MM+M @MMMnews]

How can AI, digital tools & patient connectivity improve breast cancer care? Join us LIVE on June 25 at 1 PM ET for this free webinar on designing 360-degree care systems. 🎗️

🔗 https://t.co/CnzAKi5myp

#HealthcareInnovation #BreastCancer #PatientExperience

[MM+M @MMMnews]

The 2025 Salary Survey reveals a major shift: Average pay has dipped to $161K, benefits are tightening and in-office mandates have doubled. Success now requires a blend of data, tech and strategy.

Read the full analysis: https://t.co/j1suG8bl6W

[MM+M @MMMnews]

Ready to hit start? 🎮

On June 9, the 2026 Agency 100 drops with a new high-score theme. Stay tuned to see who leveled up, explore custom agency "case art," and view the final leaderboard: https://t.co/Jl7uAvtiYh

#Agency100 #HealthcareMarketing

[MM+M @MMMnews]

According to the 2026 MM+M/Inmar Healthcare Marketers Trend Report, the overall healthcare marketing and communications market has grown to an estimated $26.52 billion this year, up from $24.55 billion in 2025. Learn more here - https://t.co/HZjIhzbLo0

[MM+M @MMMnews]

Check out pharma’s 10 most interesting booths at ASCO https://t.co/vImz7qlOwj

[MM+M @MMMnews]

🎧 This week, reporter Bella Czajkowski brings us a conversation with Chumi Khurana, SVP of U.S. oncology at @JazzPharma, to talk about her career arc, her work at an ascendant midsize drugmaker and what lessons she’s learned along the way.

Full episode: https://t.co/wC0aCSoV5N